Co-Authors
This is a "connection" page, showing publications co-authored by Matthias Tenbusch and Andreas Kremer.
Connection Strength
0.818
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
Score: 0.241
-
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):751-759.
Score: 0.227
-
Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1999-2004.
Score: 0.060
-
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1983-1997.
Score: 0.059
-
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol. 2021 06; 51(6):1436-1448.
Score: 0.059
-
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections. Nat Commun. 2021 02 18; 12(1):1112.
Score: 0.058
-
Pearls & Oy-sters: SARS-CoV-2 Infection of the CNS in a Patient With Meningeosis Carcinomatosa. Neurology. 2021 03 09; 96(10):496-499.
Score: 0.057
-
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
Score: 0.056